Search

A new centre is to develop clinical-grade embryonic stem cell lines to offer to companies and researchers free of intellectual property rights.

An obsession with the equity gap is obscuring the real reasons why universities are failing to commercialise their research, says one of the UK's leading spin-out investors.

These days, Big Pharma does not appear to have many friends. The market performance of many big pharmaceutical companies has been middling, as the sector’s competitive position is perceived to be under several threats. The drug pipeline appears to be drying up and geared more toward lifestyle enhancement than life savings. Costly and reputation-damaging liability suits are proliferating. Pricing pressures are relentless. They come from pressure groups such as AIDS patients; but they are reinforced by public authorities, not only in the developing world but also in the US and in Europe, as governments seek to slow down the relentless progress of health expenditures.

A small number of German universities will next week receive a large boost in fame and fortune as Germany seeks to restore the fortunes of its science.

The first mobile phones with built-in GPS are about to hit the market – and they are prompting a new wave of VC investment in location-based services.

Cambridge joins the ranks of universities going into print to proclaim its research excellence.

Can you relate a firms performance and its technological capability?

Two more reports from Global Watch Missions – on biocatalysts and RFID

This Battelle-R&D Magazine report on international research and development trends sees China's race into R&D as the modern day equivalent of the Cold War.

The patents juggernaut chugs out of the lay-by as Charlie McCreevy sets out his latest vision following the large scale consultation that took place earlier this year.

On September 21, 2006, the Russian Parliament approved in the first reading a new draft law on intellectual property. Following the approval, First Deputy Prime Minister Dmitry Medvedev said the draft meets international requirements set for Russia and is aimed at Russia's accession to the WTO.